HRID2530

反应详情

EQUATION

反应方程式

REACTANTS

反应物

HCID444972

Fumaric acid

C4H4O4

结构：CCCCC(=O)Nc1ccc(C(=O)N(CCN2CCC(C(=O)c3ccc(F)cc3)CC2)c2cccnc2)cc1

HCID19689857

未命名化合物

PRODUCTS

生成物

结构：CCCCC(=O)Nc1ccc(C(=O)N(CCN2CCC(C(=O)c3ccc(F)cc3)CC2)c2cccnc2)cc1.CCCCC(=O)Nc1ccc(C(=O)N(CCN2CCC(C(=O)c3ccc(F)cc3)CC2)c2cccnc2)cc1.O=C(O)/C=C/C(=O)O

HCID131720571

未命名化合物

收率 84%

PROCEDURE

实验过程

Using 4-valerylamino-N-{2-[4-(4-fluorobenzoyl)piperidino]-ethyl}-N-(3-pyridyl)benzamide (139.4 mg, 0.26 mmol) and fumaric acid (15.4 mg, 0.13 mmol), the procedure of inventive Example 271 was repeated to obtain 128.5 mg (84.0%) of the title compound in a light brown amorphous powder form.

来源与证据

来源类型: Open Reaction Database
ORD 记录: ord-7ace0fd1bbf443febb2d3c42fd67234e
来源数据集: uspto-grants-1998_03
DOI: 10.6084/m9.figshare.5104873.v1
专利: US05728835
来源说明: uspto-grants-1998_03

反应 SMILES

[C:1]([NH:7][C:8]1[CH:39]=[CH:38][C:11]([C:12]([N:14]([CH2:21][CH2:22][N:23]2[CH2:28][CH2:27][CH:26]([C:29](=[O:37])[C:30]3[CH:35]=[CH:34][C:33]([F:36])=[CH:32][CH:31]=3)[CH2:25][CH2:24]2)[C:15]2[CH:16]=[N:17][CH:18]=[CH:19][CH:20]=2)=[O:13])=[CH:10][CH:9]=1)(=[O:6])[CH2:2][CH2:3][CH2:4][CH3:5].[C:40]([OH:47])(=[O:46])/[CH:41]=[CH:42]/[C:43]([OH:45])=[O:44]>>[C:40]([OH:47])(=[O:46])/[CH:41]=[CH:42]/[C:43]([OH:45])=[O:44].[C:1]([NH:7][C:8]1[CH:39]=[CH:38][C:11]([C:12]([N:14]([CH2:21][CH2:22][N:23]2[CH2:28][CH2:27][CH:26]([C:29](=[O:37])[C:30]3[CH:35]=[CH:34][C:33]([F:36])=[CH:32][CH:31]=3)[CH2:25][CH2:24]2)[C:15]2[CH:16]=[N:17][CH:18]=[CH:19][CH:20]=2)=[O:13])=[CH:10][CH:9]=1)(=[O:6])[CH2:2][CH2:3][CH2:4][CH3:5].[C:1]([NH:7][C:8]1[CH:9]=[CH:10][C:11]([C:12]([N:14]([C:15]2[CH:16]=[N:17][CH:18]=[CH:19][CH:20]=2)[CH2:21][CH2:22][N:23]2[CH2:28][CH2:27][CH:26]([C:29](=[O:37])[C:30]3[CH:31]=[CH:32][C:33]([F:36])=[CH:34][CH:35]=3)[CH2:25][CH2:24]2)=[O:13])=[CH:38][CH:39]=1)(=[O:6])[CH2:2][CH2:3][CH2:4][CH3:5]